{"entity":{"type":"insider","cik":"0001764139","url":"/insider/0001764139","json_url":"/insider/0001764139.json","name":"Mullennix Stephen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2019-03-07","last":"2020-04-28","span_basis":"filed_date"},"name_variants":[{"name":"Mullennix Stephen","source":"filing","n_filings":7,"first_seen":"2019-03-07","last_seen":"2020-04-28"}],"transactions":[{"id":2369253,"accession":"0001209191-20-025893","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025893","line_url":"/filing/0001209191-20-025893#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145.0,"shares_display":"145","price_per_share":24.35,"price_display":"24.35","price_state":"stated","total_value":3530.75,"total_display":"3,530.75","total_whole":"3,531","shares_owned_after":10084.0,"shares_owned_after_display":"10,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-28","scope":"insider"},{"id":2224683,"accession":"0001209191-20-009943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-009943","line_url":"/filing/0001209191-20-009943#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":612.0,"shares_display":"612","price_per_share":28.04,"price_display":"28.04","price_state":"stated","total_value":17160.48,"total_display":"17,160.48","total_whole":"17,160","shares_owned_after":9812.0,"shares_owned_after_display":"9,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-18","scope":"insider"},{"id":3086357,"accession":"0001209191-20-005211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-005211","line_url":"/filing/0001209191-20-005211#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":684.0,"shares_display":"684","price_per_share":29.26,"price_display":"29.26","price_state":"stated","total_value":20013.84,"total_display":"20,013.84","total_whole":"20,014","shares_owned_after":8665.0,"shares_owned_after_display":"8,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-28","scope":"insider"},{"id":8728898,"accession":"0001209191-19-056923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056923","line_url":"/filing/0001209191-19-056923#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608.0,"shares_display":"608","price_per_share":25.9973,"price_display":"26.00","price_state":"stated","total_value":15806.3584,"total_display":"15,806.36","total_whole":"15,806","shares_owned_after":7683.0,"shares_owned_after_display":"7,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"},{"id":8759342,"accession":"0001209191-19-046282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-046282","line_url":"/filing/0001209191-19-046282#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608.0,"shares_display":"608","price_per_share":31.65,"price_display":"31.65","price_state":"stated","total_value":19243.2,"total_display":"19,243.20","total_whole":"19,243","shares_owned_after":6532.0,"shares_owned_after_display":"6,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":7978711,"accession":"0001209191-19-030594","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-030594","line_url":"/filing/0001209191-19-030594#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608.0,"shares_display":"608","price_per_share":37.98,"price_display":"37.98","price_state":"stated","total_value":23091.84,"total_display":"23,091.84","total_whole":"23,092","shares_owned_after":5381.0,"shares_owned_after_display":"5,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-16","scope":"insider"},{"id":8645149,"accession":"0001209191-19-017932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-017932","line_url":"/filing/0001209191-19-017932#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001764139","owner_name":"Mullennix Stephen","owner_display_name":"Mullennix Stephen","owner_url":"/insider/0001764139","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2804.0,"shares_display":"2,804","price_per_share":37.3,"price_display":"37.30","price_state":"stated","total_value":104589.2,"total_display":"104,589.20","total_whole":"104,589","shares_owned_after":4230.0,"shares_owned_after_display":"4,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-03-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001668243","name":"UroGen Pharma Ltd.","url":"/issuer/0001668243","role":"Officer (Chief Operating Officer)","n_filings":7,"first_seen":"2019-03-07","last_seen":"2020-04-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001764139","retrieved_at":"2026-08-26T23:26:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}